Letters to the Editor

Novel tripartite CPSF7::RARG::CPSF7 fusion confers primary ATRA resistance in atypical acute promyelocytic leukemia

Precision Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing
Department of Blood Transfusion, The First Affiliated Hospital of Nanchang University, Nanchang
Department of Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang
Department of Clinical Laboratory, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang
Precision Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China; Division of Pathology and Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang
Division of Pathology and Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang
Division of Pathology and Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang
Division of Pathology and Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang
Division of Pathology and Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang
Precision Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China; Division of Pathology and Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang
Precision Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China; Division of Pathology and Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang
Division of Pathology and Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang
Division of Pathology and Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang
Department of Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang
Precision Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China; Division of Pathology and Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China; Division of Pathology and Laboratory Medicine, Beijing Lu Daopei Hospital, Beijing
Haematologica Early view May 28, 2026 https://doi.org/10.3324/haematol.2026.300904